Back
Aytu Biopharma, Inc. 10K Form
Sell
43
AYTU
Aytu Biopharma, Inc.
Last Price:
$2.69
Seasonality Move:
-12.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AYTU News And Ratings
See the #1 stock for the next 7 days that we like better than AYTU
AYTU Financial Statistics
Sales & Book Value
| Annual Sales: | $66.4M |
|---|---|
| Cash Flow: | $3.7M |
| Price / Cash Flow: | 28.82 |
| Annual Sales: | $1.32 |
| Price / Book: | 2.06 |
Profitability
| EPS (TTM): | -3.83870 |
|---|---|
| Net Income (TTM): | $-24.6M |
| Gross Margin: | $42.1M |
| Return on Equity: | -100.65% |
| Return on Assets: | -20.07% |
Aytu Biopharma, Inc. Earnings Forecast
Key Aytu Biopharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 21 years for AYTU is 63.49%.
-
The Selling, General & Administrative Expenses for AYTU have been equal to 57.67% of Gross Profit Margin.
-
The Research & Development expenses have been 2.00% of Revenue.
-
The Net Earning history of AYTU is -21.36% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 9 years.
Aytu Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AYTU |
| CUSIP: | 054754 |
| Website: | aytubio.com |
Debt
| Debt-to-Equity Ratio: | 1.56 |
|---|---|
| Current Ratio: | 1.16 |
| Quick Ratio: | 0.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16.06 |
AYTU Technical Analysis vs Fundamental Analysis
Sell
43
Aytu Biopharma, Inc. (AYTU)
is a Sell
Is Aytu Biopharma, Inc. a Buy or a Sell?
-
Aytu Biopharma, Inc. stock is rated a SellThe current Aytu Biopharma, Inc. [AYTU] share price is $2.68. The Score for AYTU is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.